These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18325033)

  • 21. Novel 2-(substituted phenyl)benzimidazole derivatives with potent activity against IgE, cytokines, and CD23 for the treatment of allergy and asthma.
    Richards ML; Lio SC; Sinha A; Tieu KK; Sircar JC
    J Med Chem; 2004 Dec; 47(26):6451-4. PubMed ID: 15588078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [IgE-Fc(epsilon)RI-mast cell paradigm revisited].
    Ra C
    Arerugi; 2003 Jul; 52(7):573-81. PubMed ID: 12928605
    [No Abstract]   [Full Text] [Related]  

  • 23. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R; Hansel TT
    Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast cell and eosinophil surface receptors as targets for anti-allergic therapy.
    Gangwar RS; Landolina N; Arpinati L; Levi-Schaffer F
    Pharmacol Ther; 2017 Feb; 170():37-63. PubMed ID: 27773785
    [No Abstract]   [Full Text] [Related]  

  • 25. The human IgE network.
    Sutton BJ; Gould HJ
    Nature; 1993 Dec; 366(6454):421-8. PubMed ID: 8247150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive and negative regulatory mechanisms in high-affinity IgE receptor-mediated mast cell activation.
    Roth K; Chen WM; Lin TJ
    Arch Immunol Ther Exp (Warsz); 2008; 56(6):385-99. PubMed ID: 19082920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.
    Fukuda K; Ohbayashi M; Morohoshi K; Zhang L; Liu FT; Ono SJ
    J Allergy Clin Immunol; 2009 Oct; 124(4):827-33.e2. PubMed ID: 19660804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunoglobulin E-Toll-like receptor network.
    Novak N; Bieber T; Peng WM
    Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of IgE-mediated allergic reactions.
    Bloebaum RM; Dharajiya N; Grant JA
    Clin Allergy Immunol; 2004; 18():65-84. PubMed ID: 15042909
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term cultured human skin mast cells are suitable for pharmacological studies of anti-allergic drugs due to high responsiveness to FcεRI cross-linking.
    Guhl S; Artuc M; Neou A; Babina M; Zuberbier T
    Biosci Biotechnol Biochem; 2011; 75(2):382-4. PubMed ID: 21307580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconstitution of anti-allergic activities of PG102 derived from Actinidia arguta by combining synthetic chemical compounds.
    Kim D; Choi J; Kim MJ; Kim SH; Cho SH; Kim S
    Exp Biol Med (Maywood); 2013 Jun; 238(6):631-40. PubMed ID: 23918875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-allergic effects of phlorotannins on histamine release via binding inhibition between IgE and Fc epsilonRI.
    Li Y; Lee SH; Le QT; Kim MM; Kim SK
    J Agric Food Chem; 2008 Dec; 56(24):12073-80. PubMed ID: 19053379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urticaria and angioedema].
    Miyachi Y
    Ryoikibetsu Shokogun Shirizu; 2000; (31):543-6. PubMed ID: 11269158
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets.
    Klein O; Ngo-Nyekel F; Stefanache T; Torres R; Salomonsson M; Hallgren J; Rådinger M; Bambouskova M; Campbell M; Cohen-Mor S; Dema B; Rose CG; Abrink M; Charles N; Ainooson G; Paivandy A; Pavlova VG; Serrano-Candelas E; Yu Y; Hellman L; Jensen BM; Van Anrooij B; Grootens J; Gura HK; Stylianou M; Tobio A; Blank U; Öhrvik H; Maurer M
    Scand J Immunol; 2016 Jun; 83(6):465-72. PubMed ID: 27028428
    [No Abstract]   [Full Text] [Related]  

  • 35. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mode of action of anti-allergic drugs.
    Kay AB
    Clin Allergy; 1987 Mar; 17(2):153-64. PubMed ID: 2884054
    [No Abstract]   [Full Text] [Related]  

  • 37. The ins and outs of IgE-dependent mast-cell exocytosis.
    Blank U; Rivera J
    Trends Immunol; 2004 May; 25(5):266-73. PubMed ID: 15099567
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of various anti-allergic agents on IgE-mediated anaphylactic alterations of pulmonary function in rats.
    Menassé R; Ferrini PG; Niderhauser U; Szeszak J
    Monogr Allergy; 1979; 14():126-9. PubMed ID: 116122
    [No Abstract]   [Full Text] [Related]  

  • 39. Mast cell stabilizers for the relief of allergic conjunctivitis.
    Bataoel A
    Insight; 2007; 32(1):25. PubMed ID: 17533783
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.
    Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.